Cite
Sunder-Plassmann G, Hörl WH. Pathophysiology and Treatment of Hyperhomocysteinemia in End-Stage Renal Disease Patients. Hemodial Int. 2001;5(1):86-91doi: 10.1111/hdi.2001.5.1.86.
Sunder-Plassmann, G., & Hörl, W. H. (2001). Pathophysiology and Treatment of Hyperhomocysteinemia in End-Stage Renal Disease Patients. Hemodialysis international. International Symposium on Home Hemodialysis, 5(1), 86-91. https://doi.org/10.1111/hdi.2001.5.1.86
Sunder-Plassmann, G, and Hörl, Walter H. "Pathophysiology and Treatment of Hyperhomocysteinemia in End-Stage Renal Disease Patients." Hemodialysis international. International Symposium on Home Hemodialysis vol. 5,1 (2001): 86-91. doi: https://doi.org/10.1111/hdi.2001.5.1.86
Sunder-Plassmann G, Hörl WH. Pathophysiology and Treatment of Hyperhomocysteinemia in End-Stage Renal Disease Patients. Hemodial Int. 2001 Jan;5(1):86-91. doi: 10.1111/hdi.2001.5.1.86. PMID: 28452434.
Copy
Download .nbib